Platelet-to-Lymphocyte Ratio as Marker of Platelet Activation in Patients on Potent P2Y Inhibitors

Platelet-to-Lymphocyte Ratio as Marker of Platelet Activation in Patients on Potent P2Y Inhibitors

A high platelet-to-lymphocyte ratio (PLR) has recently been associated with ischemic outcomes in cardiovascular disease. Increased platelet reactivity and leukocyte-platelet aggregate formation are directly involved in the progress of atherosclerosis and have been linked to ischemic events following...

Full description

Bibliographic Details
Main Authors: Patricia P. Wadowski MD, PhD, Joseph Pultar, Constantin Weikert, Beate Eichelberger, Maximilian Tscharre MD, PhD, Renate Koppensteiner MD, Simon Panzer MD, Thomas Gremmel MD, MBA
Format: Article
Language:English
Published: SAGE Publishing 2022-04-01
Series:Journal of Cardiovascular Pharmacology and Therapeutics
Online Access:https://doi.org/10.1177/10742484221096524

Internet

https://doi.org/10.1177/10742484221096524

Similar Items